儿科贴片检测的表征:回顾性审查,2020-2023年
Caroline Brumley1,2, Puneet Arora1,2, Sara A Hylwa1,3,4
1From the Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota, USA.
Dermatitis : contact, atopic, occupational, drug
|June 24, 2024
概括
儿科过敏性接触性皮肤炎 (ACD) 影响儿童和成人相同. 关键的过敏原包括香料和乳化剂,有些不属于标准的北美测试系列.
科学领域:
- 皮肤病学 皮肤病学
- 过敏学 过敏学
- 儿科健康 儿科健康
背景情况:
- 过敏性接触性皮肤炎 (ACD) 影响儿童和成人,但儿科病例在贴片测试研究中代表性不足.
- 有限的数据存在于特定的儿科ACD患病率和常见的过敏原.
- 儿童占贴片测试对象的不到10%,需要专注的儿科研究.
研究的目的:
- 描述一个在北美中心接受补丁测试的儿科队列.
- 为了确定疑似ACD的儿童的常见过敏原和敏感化率.
- 分析个人产品和非标准过敏原在儿科ACD中的相关性.
主要方法:
- 在2020年7月至2023年8月期间测试的135名1至17岁患者的回顾性图表审查.
- 根据年龄组分层的数据:1-5岁,6-11岁,12-17岁.
- 显著性-流行指数数 (SPIN) 计算出过敏原相关性.
主要成果:
- 86%的儿科患者受到敏感化,其中40%经历了相关反应.
- 阳性率在男性和女性之间是平等的.
- 最常见的过敏原包括林纳醇氧化物,烯糖醇,利蒙氧化物,香料混合物I和兰诺林. 乳化剂和香料是关键类别.
结论:
- ACD对儿科男性和女性的影响是一样的.
- 14%的被确定的顶级过敏原不在标准的北美接触性皮肤炎组系列中.
- 用补充过敏原和个人产品进行测试对于准确的儿科ACD诊断至关重要.
更多相关视频
06:31Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
8.6K
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.2K
相关概念视频
Patch Clamp
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
